Grotegut Chad A, Tatineni Harati, Dandolu Vani, Whiteman Valerie E, Katari Sunita, Geifman-Holtzman Ossie
Department of Obstetrics, Gynecology and Reproductive Sciences, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
J Matern Fetal Neonatal Med. 2008 May;21(5):315-20. doi: 10.1080/14767050801909564.
Pregnancies complicated by a false-positive one-hour glucose challenge test (GCT), as determined by the National Diabetes Data Group (NDDG) criteria, have higher rates of adverse maternal and neonatal outcomes. This study was conducted to determine if pregnancies complicated by a false-positive GCT, as determined by the Carpenter-Coustan (CC) criteria, also have higher rates of adverse maternal and neonatal outcomes.
In this retrospective case-control study, we compared 165 patients with a false-positive GCT, as determined by the Carpenter-Coustan criteria, to a cohort of 165 pregnant controls with a normal screening GCT. Multiple variables for maternal and neonatal outcomes were compared between the two groups.
The racial distribution and gestational age of delivery were similar in both groups. The study group had a higher one-hour GCT (148.2 mg/dl vs. 95.3 mg/dl, p < 0.001), was older (27.4 yrs vs. 23.8 years, p < 0.001), was more likely to be multiparous (71.5% vs. 58.2%, p = 0.011), and had a higher BMI (26.7 kg/m2 vs. 24.6 kg/m2, p = 0.002). There were no differences between the two groups in mode of delivery, birth weight, rates of macrosomia, shoulder dystocia, antenatal death and maternal laceration. There were also no differences between the two groups in rates of preeclampsia, chorioamnionitis, endometritis, ICN admission, neonatal hypoglycemia, Erb's palsy, clavicular fracture, neonatal sepsis, neonatal death or use of phototherapy.
Women with a false-positive one-hour GCT by the Carpenter-Coustan criteria do not have higher rates of adverse perinatal outcomes. Using the Carpenter-Coustan criteria to diagnose GDM appears to be superior to NDDG criteria in terms of avoiding adverse maternal and neonatal outcomes.
根据美国国家糖尿病数据组(NDDG)标准判定为妊娠合并假阳性一小时葡萄糖耐量试验(GCT)的孕妇,出现不良母婴结局的几率更高。本研究旨在确定,根据卡彭特-库斯坦(CC)标准判定为妊娠合并假阳性GCT的孕妇,其不良母婴结局的发生率是否也更高。
在这项回顾性病例对照研究中,我们将165例根据卡彭特-库斯坦标准判定为GCT假阳性的患者,与165例筛查GCT结果正常的妊娠对照组进行了比较。对两组间母婴结局的多个变量进行了比较。
两组的种族分布和分娩孕周相似。研究组的一小时GCT值更高(148.2mg/dl对95.3mg/dl,p<0.001),年龄更大(27.4岁对23.8岁,p<0.001),多产的可能性更大(71.5%对58.2%,p=0.011),且体重指数更高(26.7kg/m²对24.6kg/m²,p=0.002)。两组在分娩方式、出生体重、巨大儿发生率、肩难产、产前死亡和母体撕裂方面无差异。两组在子痫前期、绒毛膜羊膜炎/羊膜囊炎、子宫内膜炎、入住重症监护病房(ICN)、新生儿低血糖、臂丛神经麻痹、锁骨骨折、新生儿败血症、新生儿死亡或光疗使用方面也无差异。
根据卡彭特-库斯坦标准判定为一小时GCT假阳性的女性,其围产期不良结局的发生率并不更高。在避免不良母婴结局方面,使用卡彭特-库斯坦标准诊断妊娠期糖尿病(GDM)似乎优于NDDG标准。